The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $617,868 Project Grant to the Regents of the University of Minnesota's Office of Sponsored Projects Administration. The grant, awarded on July 15, 2024, will fund the "Evaluation of Novel TRIKE-PACC Molecule to Amplify Natural Killer Cell Function in Mesothelioma" research project. The objective is to investigate an innovative therapeutic approach to enhance natural killer cell function in treating mesothelioma, a type of cancer. The research will be conducted at the University of Minnesota over a 2-year period, with a planned completion date of July 14, 2026. The Military Medical Research and Development program supports a range of biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public.
Generated 1/28/25, 7:32 AM